Bortezomib/Dexamethasone Therapy in Patients With Relapsed and/or Refractory Cutaneous T-cell Lymphoma
Clinical trial NCT03487133 · COMPLETED
Trial details
- NCT number
- NCT03487133
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2020-09-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.